Pharmaceuticals Global On demand · 24-48h

Global Soft Gelatin Capsules (Softgels) Market Strategic Research Report

Global Soft Gelatin Capsules (Softgels) Market Strategic Res…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Soft Gelatin Capsules (Softgels) Market
$4.63B2025
4.5%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Gelatin, Non-gelatin (Vegan)

By Application: Health Supplements, Pharmaceutical, Others (Cosmetics, etc.)

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Catalent, Aenova, Nature’s Bounty, Sofgen Pharma, Patheon (Thermo Fisher Scientific), Aland, Ourvita (HBI EuroCaps, Braveiy), Captek, NextPharma, Soft Gel Technologies, Amway, Robinson Pharma, Pharmavite (Nature Made), Sunsho Pharmaceutical, KD Nutra, Sirio Pharma, Baihe Biotech, Ziguang Group, By-Health, Yuwang Group, Guangdong Yichao

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 156 pages
Market size 2025
$4.63B
Billion USD
Forecast CAGR
4.5%
2025-2032
Forecast 2032
$6.3B
Projected
区域
5
Asia Pacific · Latin America · MEA · Europe · North America

概述

Scope of the Report

The global Soft Gelatin Capsules (Softgels) market size is predicted to grow from US$ 4,629 million in 2025 to US$ 6,238 million in 2032; it is expected to grow at a CAGR of 4.5% from 2026 to 2032.

Soft Gelatin Capsules, also called softgels, are manufactured as single piece capsule shell. It is a type of capsule with a solid outer shell and inner surrounding a liquid or semi-solid (inner fill) active ingredient that can be incorporated into the outer shell, the inner fill, or both.

The soft capsule market is undergoing a profound transformation from "natural raw materials" to "technological innovation". The driving factors mainly include: Firstly, the acceleration of global aging and the enhanced preventive health awareness of consumers have promoted the expansion of the application of lipid-soluble nutrients such as fish oil and coenzyme Q10 in soft capsule formulations; Secondly, the maturity of plant-based soft capsules (such as starch gum and carrageenan) technology meets the diverse cultural demands of veganism, clean eating, and halal, and solves the thermal instability problem of traditional gelatin; Finally, the combination of advanced pharmaceutical processes such as microemulsification technology with soft capsules significantly improves the bioavailability of poorly soluble drugs, enabling more prescription drugs to choose soft capsules as the drug delivery carrier.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Soft Gelatin Capsules (Softgels) market?

What factors are driving Soft Gelatin Capsules (Softgels) market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Soft Gelatin Capsules (Softgels) market opportunities vary by end market size?

How does Soft Gelatin Capsules (Softgels) break out by Type, by Application?

This report presents a comprehensive overview of the global Soft Gelatin Capsules (Softgels) market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Gelatin
  • Non-gelatin (Vegan)

Segment by Function

  • Vitamins and Minerals
  • Fish Oil and Algae Oil
  • Coenzyme Q10 and Lutein
  • Pharma
  • Other

Segment by Marketing Method

  • Direct Sales
  • Distribution

Segment by Application

  • Health Supplements
  • Pharmaceutical
  • Others (Cosmetics, etc.)

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Soft Gelatin Capsules (Softgels) market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Health Supplements, Pharmaceutical, Others (Cosmetics, etc.) evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Soft Gelatin Capsules (Softgels) Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 4.5%
Regional growth momentum
Market share by segment
Key metrics
Base value
$4.63B
2025
Forecast
$6.3B
2032
CAGR
4.5%
2025–2032
区域
5
global
Key companies
CatalentAenovaNature’s BountySofgen PharmaPatheon (Thermo Fisher Scientific)AlandOurvita (HBI EuroCapsBraveiy)
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
GelatinNon-gelatin (Vegan)
By Application
Health SupplementsPharmaceuticalOthers (Cosmeticsetc.)

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Gelatin
  • 3.1.3 Non-gelatin (Vegan)
  • 3.1.4 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Health Supplements
  • 4.1.3 Pharmaceutical
  • 4.1.4 Others (Cosmetics, etc.)
  • 4.1.5 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Catalent
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Aenova
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Nature’s Bounty
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Sofgen Pharma
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Patheon (Thermo Fisher Scientific)
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 Aland
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Ourvita (HBI EuroCaps, Braveiy)
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Captek
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 NextPharma
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Soft Gel Technologies
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Amway
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Robinson Pharma
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Pharmavite (Nature Made)
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Sunsho Pharmaceutical
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 KD Nutra
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Sirio Pharma
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 Baihe Biotech
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Ziguang Group
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 By-Health
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Yuwang Group
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 Guangdong Yichao
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Soft Gelatin Capsules (Softgels) market?
The global Soft Gelatin Capsules (Softgels) market is estimated at US$ 4.63 billion in 2025 (base year) and is projected to reach US$ 6.24 billion by 2032.
What is the forecast CAGR for the Soft Gelatin Capsules (Softgels) market?
The market is expected to grow at a CAGR of 4.5% from 2026 to 2032, expanding from US$ 4.63 billion in 2025 to US$ 6.24 billion in 2032, roughly 1.3 times its base-year value.
What is Soft Gelatin Capsules (Softgels)?
Soft Gelatin Capsules, also called softgels, are manufactured as single piece capsule shell. It is a type of capsule with a solid outer shell and inner surrounding a liquid or semi-solid (inner fill) active ingredient that can be incorporated into the outer shell, the inner fill, or both.
What are the main segments of the Soft Gelatin Capsules (Softgels) market by type?
By type, the market is segmented into Gelatin and Non-gelatin (Vegan).
Which applications drive demand in the Soft Gelatin Capsules (Softgels) market?
Key applications covered include Health Supplements, Pharmaceutical and Others (Cosmetics, etc.).
Who are the key players in the Soft Gelatin Capsules (Softgels) market?
Key players profiled include Catalent, Aenova, Nature’s Bounty, Sofgen Pharma, Patheon (Thermo Fisher Scientific), Aland, Ourvita (HBI EuroCaps, Braveiy) and Captek, among 21 companies covered in total.
Which regions and countries are covered for Soft Gelatin Capsules (Softgels)?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What is driving growth in the Soft Gelatin Capsules (Softgels) market?
What factors are driving Soft Gelatin Capsules (Softgels) market growth, globally and by region?
Who should buy the Soft Gelatin Capsules (Softgels) market report?
The report is intended for manufacturers and solution providers, distributors and end users in Health Supplements, Pharmaceutical and Others (Cosmetics, etc.), investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Soft Gelatin Capsules (Softgels) market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

All data sources are cited within the report. View our full research methodology →
Select a license
from US$3,500.00
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.